SCHEMBL913181

SCHEMBL913181

O=Cc1ccc(-c2ccccc2F)nc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.49
CYP11B1 P15538 4/20 0.46
CYP11B2 P19099 2/20 0.46
IL4I1 Q96RQ9 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
GRM2 Q14416 1/20 0.44
IDO1 P14902 1/20 0.42
MPL P40238 1/20 0.41
ALDH1A1 P00352 1/20 0.41
DRD2 P14416 1/20 0.41
DRD1 P21728 1/20 0.41
DRD4 P21917 1/20 0.41
DRD5 P21918 1/20 0.41
DRD3 P35462 1/20 0.41
RAB9A P51151 1/20 0.40
ALOX5AP P20292 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27726530 0.85 CYP11B1 (0.48) NPC1CYP11B1CYP11B2IL4I1L3MBTL1
SCHEMBL10324964 0.80 MAPT (0.42) NPC1CYP11B1L3MBTL1ALDH1A1DRD2
SCHEMBL9607471 0.80 ALDH1A1 (0.45) L3MBTL1CASP3SENP8SENP7SENP6
SCHEMBL6018826 0.79 CYP11B1 (0.47) NPC1CYP11B1CYP11B2L3MBTL1IDO1
SCHEMBL2004558 0.79 IDO1 (0.42) NPC1CASP3SENP8SENP7SENP6
SCHEMBL5963839 0.79 KMO (0.43) L3MBTL1ALDH1A1ALOX5APFEN1
SCHEMBL25428723 0.79 NPC1 (0.40) NPC1L3MBTL1CASP3SENP8SENP7
SCHEMBL3610428 0.79 P4HTM (0.51) NPC1CYP11B1CYP11B2CASP3SENP8
SCHEMBL3610427 0.79 P4HTM (0.51) NPC1CYP11B1CYP11B2CASP3SENP8
SCHEMBL3652506 0.77 NPC1 (0.44) NPC1CYP11B1CYP11B2IL4I1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2279177-A1 NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Frosst Canada Ltd. (CA) 2011-02-02 EP disclosed
US-20110021532-A1 NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. 2011-01-27 US disclosed
US-20110021532-A1 NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. 2011-01-27 US disclosed
US-20110021532-A1 NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. 2011-01-27 US disclosed
WO-2009129625-A1 NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2009-10-29 WO disclosed
WO-2009129625-A1 NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021532-A1 NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, FASN NPC1 457/4885CYP11B1 93/4885CYP11B2 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.